Abstract
Objectives Neonatal hypoxic-ischemic encephalopathy is a serious neurologic condition associated with death or neurodevelopmental impairments. Magnetic resonance imaging (MRI) is routinely used for neuroprognostication, but there is substantial subjectivity and uncertainty about neurodevelopmental outcome prediction. We sought to develop an objective and automated approach for the analysis of newborn brain MRI to improve the accuracy of prognostication.
Methods We created an anatomical MRI template from a sample of 286 infants treated with therapeutic hypothermia, and labeled the deep gray-matter structures. We extracted quantitative information, including shape-related information, and information represented by complex patterns (radiomic measures), from each of these structures in all infants. We then trained an elastic net model to use either only these measures, only the infants’ clinical data, or both, to predict neurodevelopmental outcomes, as measured by the Bayley Scales of Infant and Toddler Development at 18 months of age.
Results Amongst those infants who survived and for whom Bayley scores were available for cognitive, language, and motor outcomes, we found sets of MRI-based measures that could predict their Bayley scores with correlations that were more than twice the correlations based on only the clinical data, and explained more than four times the variance in the observed scores; predictions based on the combination of the clinical and MRI-based measures were similar or marginally better.
Interpretation Our findings show that machine learning models using MRI-based measures can predict neurodevelopmental outcomes in neonates with hypoxic-ischemic encephalopathy across all neurodevelopmental domains and across the full spectrum of outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this research was provided by the TD Bank Group Charity Classic Golf Tournament.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This retrospective cohort study was conducted at the Hospital for Sick Children in Toronto, Canada. The Institutional Research Ethics Board reviewed and approved the study protocols (REB:1000064940,1000079302) and waived informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵‡ Shared senior authorship
Data Availability
Our multi-contrast population specific neonatal brain MRI template and the labels for the deep gray-matter structures can be found here: https://gin.g-node.org/johndlewis/HIE/Template/ ; the scripts used to process the data can be found here: https://gin.g-node.org/johndlewis/HIE/Tools ; and the linear regression model can be found here: https://gin.g-node.org/johndlewis/HIE/Models/.
https://gin.g-node.org/johndlewis/HIE/Template/
